Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2006 3
2007 1
2010 1
2013 2
2015 2
2016 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Risk of tumorigenicity in mesenchymal stromal cell-based therapies--bridging scientific observations and regulatory viewpoints.
Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, Büscher D, Fibbe W, Foussat A, Kwa M, Lantz O, Mačiulaitis R, Palomäki T, Schneider CK, Sensebé L, Tachdjian G, Tarte K, Tosca L, Salmikangas P. Barkholt L, et al. Among authors: jekerle v. Cytotherapy. 2013 Jul;15(7):753-9. doi: 10.1016/j.jcyt.2013.03.005. Epub 2013 Apr 18. Cytotherapy. 2013. PMID: 23602595 Review.
Modelling the risk-benefit impact of H1N1 influenza vaccines.
Phillips LD, Fasolo B, Zafiropoulous N, Eichler HG, Ehmann F, Jekerle V, Kramarz P, Nicoll A, Lönngren T. Phillips LD, et al. Among authors: jekerle v. Eur J Public Health. 2013 Aug;23(4):674-8. doi: 10.1093/eurpub/ckt006. Epub 2013 Feb 11. Eur J Public Health. 2013. PMID: 23402804
Legal basis of the Advanced Therapies Regulation.
Jekerle V, Schröder C, Pedone E. Jekerle V, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 Jan;53(1):4-8. doi: 10.1007/s00103-009-0990-6. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010. PMID: 19940965
Cell-based therapies for cardiac repair: a meeting report on scientific observations and European regulatory viewpoints.
Schüssler-Lenz M, Beuneu C, Menezes-Ferreira M, Jekerle V, Bartunek J, Chamuleau S, Celis P, Doevendans P, O'Donovan M, Hill J, Hystad M, Jovinge S, Kyselovič J, Lipnik-Stangelj M, Maciulaitis R, Prasad K, Samuel A, Tenhunen O, Tonn T, Rosano G, Zeiher A, Salmikangas P. Schüssler-Lenz M, et al. Among authors: jekerle v. Eur J Heart Fail. 2016 Feb;18(2):133-41. doi: 10.1002/ejhf.422. Epub 2015 Oct 16. Eur J Heart Fail. 2016. PMID: 26470631 Free article.
Points to consider in the development of seed stocks of pluripotent stem cells for clinical applications: International Stem Cell Banking Initiative (ISCBI).
Andrews PW, Baker D, Benvinisty N, Miranda B, Bruce K, Brüstle O, Choi M, Choi YM, Crook JM, de Sousa PA, Dvorak P, Freund C, Firpo M, Furue MK, Gokhale P, Ha HY, Han E, Haupt S, Healy L, Hei DJ, Hovatta O, Hunt C, Hwang SM, Inamdar MS, Isasi RM, Jaconi M, Jekerle V, Kamthorn P, Kibbey MC, Knezevic I, Knowles BB, Koo SK, Laabi Y, Leopoldo L, Liu P, Lomax GP, Loring JF, Ludwig TE, Montgomery K, Mummery C, Nagy A, Nakamura Y, Nakatsuji N, Oh S, Oh SK, Otonkoski T, Pera M, Peschanski M, Pranke P, Rajala KM, Rao M, Ruttachuk R, Reubinoff B, Ricco L, Rooke H, Sipp D, Stacey GN, Suemori H, Takahashi TA, Takada K, Talib S, Tannenbaum S, Yuan BZ, Zeng F, Zhou Q. Andrews PW, et al. Among authors: jekerle v. Regen Med. 2015;10(2 Suppl):1-44. doi: 10.2217/rme.14.93. Regen Med. 2015. PMID: 25675265 No abstract available.